Clinical Capabilities Privately owned multispecialty clinical research groups with over 1500 trials in 25 years, strong Phase I throughput, and site within UT Medical Center enabling first-in-man and complex trials to support sponsor development timelines.

Strategic Locations AMR Knoxville operates a 52-bed Phase I unit with 24/7 critical care coverage and access to special populations, while AMR New Orleans complements late-phase studies across diverse specialties, offering geographic and patient diversity leverage for multi-region trials.

Quality and Data Dedicated regulatory, data, and recruiting departments plus a track record of delivering high-quality, clean data and consistently meeting enrollment goals, boosting sponsor confidence and trial reliability.

Readiness for COVID Era Historical involvement in COVID-19 vaccine candidate trials demonstrates rapid mobilization and clinical operations readiness, signaling potential for future infectious disease or accelerated program opportunities.

Growth Signals Revenue range listed at 10 to 25 million with a compact team of 11-50 employees, indicating a lean, high-efficiency operation attractive for sponsors seeking nimble CRO partners with scalable capacity.